Search
for
Sort by
Research 871–900 of 1000+
- Finding Long-COVID: temporal topic modeling of electronic health records from the N3C and RECOVER programs
- Intermittent chronic telogen effluvium with an unusual dermoscopic finding
- Associations of telogen effluvium with coronavirus disease 2019 and research progress in its diagnosis and treatment
- FEATURES OF DIAGNOSIS OF POSTCOVID ALOPECIA
- Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
- APPROACHING ALOPECIA TREATMENT VIA POLYMERIC NANOPARTICLES: A BRIEF OVERVIEW
- Hair Sciences
- SARS-CoV-2 infection reduces the number of spermatogonial stem cells and dysregulates the transcriptional landscape of the human testis
- Hair Root Dermoscopy from Shed Hair: A Simple Diagnostic Tool in Telogen Effluvium
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Minoxidil Promotes Hair Growth in a Mouse Model of Telogen Effluvium Induced by Lipopolysaccharide
- Equine Hoof Stem Progenitor Cells (HPC) CD29 + /Nestin + /K15 + – a Novel Dermal/epidermal Stem Cell Population With a Potential Critical Role for Laminitis Treatment
- A IMPORTÂNCIA DA ATENÇÃO FARMACÊUTICA DIANTE DO AUMENTO DA PRESCRIÇÃO E USO INDISCRIMINADO DE ANSIOLÍTICOS COM FOCO NOS BENZODIAZEPÍNICOS E NA PASSIFLORA INCARNATA L.
- Proceedings of the III International Scientific and Practical Conference
- Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes
- COVID-19 and Sex Differences
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Skin checks and skin cancer diagnosis in Australian general practice before and during the COVID‐19 pandemic, 2011–2020
- Alopecia areata and subsequent Marie Antoinette syndrome following COVID-19 infection and vaccination: A case report
- 222 Severe COVID-19 infection predisposes patients to greater burden of hair loss
- Efficacy of Dr. SKS hair booster serum for the treatment of hair loss in COVID-19 induced persistent telogen effluvium
- COVID-19-associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study.
- COVID-19 Severity and Androgen Receptor Polymorphism
- Case Report: Reversing Gray Hair Associated With COVID-19: A Coincidence or a Clue?
- Why we should treat COVID-19 Long-Hauler Syndromes with Convalescent Plasma; Contained Suppressive Exosomes are likely COVID antigen-specific
- Reporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Evaluation of the Relationship between Favipiravir Use Status and Telogen Effluvium in Patients Diagnosed with COVID-19
- Is there a POST‐COVID dermatological syndrome? The integrated dermato‐infectious disease experience of a single centre
- Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive study, Winter 2022.